Annual ReportFiscal Year Ended Mar. 31, 2012
- To Our Stakeholders
- Introducing the New Management Structure
- Introducing the New Management
- Interview with the Chairman
- Corporate Governance
- Comments from Outside Directors
- President Hiroyuki Sasa Discusses the Medium-Term Vision: Back to Basics
- SPECIAL FEATURE Olympus Medical Technology
- At a Glance
- Medical Business
- Life Science & Industrial Business
- Imaging Business
- Information & Communication Business
- Others
- Intellectual Property Report
- Board of Directors, Corporate Auditors and Executive Officers
- Financial Highlights
- Financial Review
- Business Risks
- Consolidated Financial Statements
- Other Financial Data
- Olympus Group Companies
- Investor Information
- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012